There are multiple strategies aimed at extending the half-life of GLP-1 and enhancing its efficacy (as shown in Figure 1) [1]
A placebo-controlled, double-blind, phase II clinical trial (the ELAD trial) testing liraglutide in over 200 patients with mild cognitive impairments/AD for 1 year showed that neuronal loss was reduced by the drug (Colin et al
However, patients should carry a copy of their prescription or a letter from their healthcare provider, particularly for international travel, to facilitate customs clearance and demonstrate medical necessity
Maintenance Doses and Long-Term Weight Management Once you reach a maintenance dose where you experience satisfactory appetite reduction and steady weight loss, you typically remain at that dose as long as you're continuing treatment
Look for an online provider who offers virtual consultations and can prescribe GLP-1 medications like tirzepatide
Documentation, not claims Every batch ships with a verified certificate of analysis (COA) confirming identity and purity